To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, Department of Health and Human Services, Food and Drug Administration, for fiscal year 2024.

This bill sets a spending cap of $5.58 billion for the Food and Drug Administration (FDA) and related agencies within the Department of Health and Human Services (HHS) for fiscal year 2024. It directly affects the FDA's budget authority by restricting the total funds it can access during the fiscal year. The key provision is a hard limit on available funds, preventing the use of any amount exceeding $5,584,965,000. This is a straightforward budgetary restriction with no additional policy mechanisms or program changes.